SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                                  FORM 8-K

                               CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF
                    THE SECURITIES EXCHANGE ACT OF 1934


    Date of report (Date of earliest event reported): September 19, 2000


                           ENDOSONICS CORPORATION
             (Exact Name of Registrant as Specified in Charter)


                                  Delaware
               (State or Other Jurisdiction of Incorporation)


                   0-19880                                 68-0028500
          (Commission File Number)                     (IRS Employer
                                                       Identification No.)


             2870 Kilgore Road
         Rancho Cordova, California                             95670
  (Address of Principal Executive Offices)                   (Zip Code)


     Registrant's telephone number, including area code: (916) 638-8008


                               Not Applicable
       (Former name or former address, if changed since last report)




ITEM 1.        CHANGES IN CONTROL OF REGISTRANT.

        On September 19, 2000, JOMED N.V., a corporation organized under
the laws of The Netherlands ("Parent"), through JOMED Acquisition Corp., a
Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser"),
accepted for purchase 16,593,039 shares of the common stock, par value
$.001 per share (the "Shares"), of EndoSonics Corporation, a Delaware
corporation (the "Company"), that had been validly tendered and not
withdrawn pursuant to Purchaser's tender offer for all of the outstanding
Shares at $11.00 per Share, net to the seller in cash (the "Offer"). Of the
16,593,039 shares accepted for purchase pursuant to the Offer, 478,737 were
tendered through notices of guarnanteed delivery. The Offer was made
pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated
as of August 5, 2000 by and among the Company, Parent and Purchaser, which
provides for, among other things, the making of the Offer by Purchaser and,
following the consummation of the Offer, the merger of Purchaser with and
into the Company (the "Merger"), with the Company as the surviving
corporation in the Merger. The Shares purchased pursuant to the Offer
constitute approximately 91.31% of the Shares issued and outstanding. The
aggregate purchase price for the Shares purchased pursuant to the Offer was
$182,523,429. In addition, Parent owns 268,100 Shares that were purchased
prior to the commencement of the Offer. Following the expiration of the
Offer and the consummation of the transactions described herein, Parent now
owns approximately 92.78% of the Shares issued and outstanding. Purchaser
obtained all funds needed for such purchase through a capital contribution
from Parent. Parent obtained such funds received from an offering of
JOMED's ordinary shares plus its existing resources and internally
generated funds, including short-term borrowing in the ordinary course of
business to finance the purchase.

        On the date on which the Certificate of Merger has been duly filed
with the Secretary of State of the State of Delaware or such time as agreed
upon by the Parent, the Purchaser and the Company and specified in the
Certificate of Merger, the Merger provided for by the Merger Agreement will
become effective. Pursuant to the Merger, Shares which are not validly
tendered pursuant to the Offer and accepted for purchase by Purchaser (and
whose holders have not sought appraisal of their Shares in accordance with
applicable provisions of Delaware law) will be converted into the right to
receive $11.00 per Share, net to the seller in cash, upon delivery of
appropriate documentation to the Paying Agent for the Offer. As a result of
the Merger, Parent will own 100% of the outstanding Shares of the Company.

        The closing of the Merger shall take place at 10:00 a.m., local
time, on the later to occur of (a) the day of (and immediately following)
the receipt of approval of the Merger by the Company's stockholders, or as
soon as practicable (and in any event not more than five business days)
after expiration of the Offer if such approval is not required and (b) a
date to be specified by Parent, Purchaser and the Company, which shall be
no later than the second business day after satisfaction or waiver of all
of the conditions set forth in the Merger Agreement, at the offices of
Skadden, Arps, Slate, Meagher & Flom, Four Times Square, New York, New
York, unless another date or place is agreed to in writing by Parent,
Purchaser and the Company.

        In accordance with the terms of the Merger Agreement, among other
things, after the Merger, the Board of Directors of the Company is composed
of the members of the Board of Directors of Parent and existing members of
the Board of Directors of the Company. The members of the Board of
Directors of Parent in the Board of Directors of the Company constitute a
majority of directors in the Board of Directors of the Company. The
Company's Board of Directors intends to appoint certain new officers of the
Company in accordance with the Company's bylaws.

        To the knowledge of the Company, except as set forth herein, there
are no arrangements, including any pledge by any person of securities of
the Company, the operation of which may at a subsequent date result in a
further change in control of the Company.


                                 SIGNATURE

               Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.


Date:  September 19, 2000                   ENDOSONICS CORPORATION


                                            By: /s/ REINHARD WARNKING
                                                ------------------------------
                                                Name:  Reinhard Warnking
                                                Title: President and CEO
[{"type": "8-K", "sequence": "1", "filename": "0001.txt", "secsgml_size_bytes": 6158}]
{"company-data": {"conformed-name": "ENDOSONICS CORP", "cik": "0000883420", "assigned-sic": "3845", "irs-number": "680028500", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-19880", "film-number": "725433"}, "business-address": {"street1": "2870 KILGORE ROAD", "city": "RANCHO CORDOVA", "state": "CA", "zip": "95670", "phone": "9166388008"}, "mail-address": {"street1": "2870 KILGORD ROAD", "city": "RANCHO CORDOVA", "state": "CA", "zip": "95670"}}
SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                                  FORM 8-K

                               CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF
                    THE SECURITIES EXCHANGE ACT OF 1934

    Date of report (Date of earliest event reported): September 19, 2000

                           ENDOSONICS CORPORATION
             (Exact Name of Registrant as Specified in Charter)

                                  Delaware
               (State or Other Jurisdiction of Incorporation)

                   0-19880                                 68-0028500
          (Commission File Number)                     (IRS Employer
                                                       Identification No.)

             2870 Kilgore Road
         Rancho Cordova, California                             95670
  (Address of Principal Executive Offices)                   (Zip Code)

     Registrant's telephone number, including area code: (916) 638-8008

                               Not Applicable
       (Former name or former address, if changed since last report)

ITEM 1.        CHANGES IN CONTROL OF REGISTRANT.

        On September 19, 2000, JOMED N.V., a corporation organized under
the laws of The Netherlands ("Parent"), through JOMED Acquisition Corp., a
Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser"),
accepted for purchase 16,593,039 shares of the common stock, par value
$.001 per share (the "Shares"), of EndoSonics Corporation, a Delaware
corporation (the "Company"), that had been validly tendered and not
withdrawn pursuant to Purchaser's tender offer for all of the outstanding
Shares at $11.00 per Share, net to the seller in cash (the "Offer"). Of the
16,593,039 shares accepted for purchase pursuant to the Offer, 478,737 were
tendered through notices of guarnanteed delivery. The Offer was made
pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated
as of August 5, 2000 by and among the Company, Parent and Purchaser, which
provides for, among other things, the making of the Offer by Purchaser and,
following the consummation of the Offer, the merger of Purchaser with and
into the Company (the "Merger"), with the Company as the surviving
corporation in the Merger. The Shares purchased pursuant to the Offer
constitute approximately 91.31% of the Shares issued and outstanding. The
aggregate purchase price for the Shares purchased pursuant to the Offer was
$182,523,429. In addition, Parent owns 268,100 Shares that were purchased
prior to the commencement of the Offer. Following the expiration of the
Offer and the consummation of the transactions described herein, Parent now
owns approximately 92.78% of the Shares issued and outstanding. Purchaser
obtained all funds needed for such purchase through a capital contribution
from Parent. Parent obtained such funds received from an offering of
JOMED's ordinary shares plus its existing resources and internally
generated funds, including short-term borrowing in the ordinary course of
business to finance the purchase.

        On the date on which the Certificate of Merger has been duly filed
with the Secretary of State of the State of Delaware or such time as agreed
upon by the Parent, the Purchaser and the Company and specified in the
Certificate of Merger, the Merger provided for by the Merger Agreement will
become effective. Pursuant to the Merger, Shares which are not validly
tendered pursuant to the Offer and accepted for purchase by Purchaser (and
whose holders have not sought appraisal of their Shares in accordance with
applicable provisions of Delaware law) will be converted into the right to
receive $11.00 per Share, net to the seller in cash, upon delivery of
appropriate documentation to the Paying Agent for the Offer. As a result of
the Merger, Parent will own 100% of the outstanding Shares of the Company.

        The closing of the Merger shall take place at 10:00 a.m., local
time, on the later to occur of (a) the day of (and immediately following)
the receipt of approval of the Merger by the Company's stockholders, or as
soon as practicable (and in any event not more than five business days)
after expiration of the Offer if such approval is not required and (b) a
date to be specified by Parent, Purchaser and the Company, which shall be
no later than the second business day after satisfaction or waiver of all
of the conditions set forth in the Merger Agreement, at the offices of
Skadden, Arps, Slate, Meagher & Flom, Four Times Square, New York, New
York, unless another date or place is agreed to in writing by Parent,
Purchaser and the Company.

        In accordance with the terms of the Merger Agreement, among other
things, after the Merger, the Board of Directors of the Company is composed
of the members of the Board of Directors of Parent and existing members of
the Board of Directors of the Company. The members of the Board of
Directors of Parent in the Board of Directors of the Company constitute a
majority of directors in the Board of Directors of the Company. The
Company's Board of Directors intends to appoint certain new officers of the
Company in accordance with the Company's bylaws.

        To the knowledge of the Company, except as set forth herein, there
are no arrangements, including any pledge by any person of securities of
the Company, the operation of which may at a subsequent date result in a
further change in control of the Company.

                                 SIGNATURE

               Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.

Date:  September 19, 2000                   ENDOSONICS CORPORATION

                                            By: /s/ REINHARD WARNKING
                                                ------------------------------
                                                Name:  Reinhard Warnking
                                                Title: President and CEO